A-share pharmaceutical sector surges in afternoon trading, Guoxin Health and others hit daily limit up

市场行情··Read original
2▲3 ▼0Impact / 5
Summary · why it matters

Today, the pharmaceutical sector in the A-share market was active, with the DRG/DIP sub-sector leading gains. ST Rongke hit the 20 percent daily limit up, while Inspur Software, Saili Medical, and Guoxin Health also reached their daily limit up. In terms of news, the National Administration of Traditional Chinese Medicine and 10 other departments jointly issued the Action Plan for the Traditional Chinese Medicine Component of the Medical and Health Foundation Strengthening Project, aiming to enhance the supply of traditional Chinese medicine services at the grassroots level. About one minute after the afternoon session opened, Guoxin Health surged straight to its daily limit up, with its stock price reaching 7.17 yuan per share and its latest market capitalization at 7.021 billion yuan. Guoxin Health primarily engages in comprehensive medical insurance management services, offering DRG, DIP, and other diversified payment method services to medical insurance clients, and leveraging AI technology to provide solutions for medical institutions and disease control departments.

Impact on assets 4

Semiconductors▲ · 1 stocks
Others▲ · 3 stocks
Inspur Software Co Ltd
600756
▲ PositiveRegulationrelevance

Mentioned as hitting daily limit up amid sector rally driven by government policy support for traditional Chinese medicine.

Wuhan Thalys Med Tech Co Ltd
603716
▲ PositiveRegulationrelevance

Mentioned as hitting daily limit up amid sector rally driven by government policy support for traditional Chinese medicine.

© 2026 MarketIVNews